PURPOSE: This study evaluated rates of BRCA1 and BRCA2 (BRCA1/2) test result acceptance among African American women and identified determinants of test result acceptance. METHODS: Acceptance of BRCA1/2 test results was evaluated among 157 African American women at high and moderate risk for having a BRCA1/2 mutation who were offered genetic testing as part of a clinical genetic counseling research program. RESULTS: Twenty-two percent of women received BRCA1/2 test results. Test result acceptance differed between women with > or =10% prior probability of having a BRCA1/2 mutation (34%) and those who had a 5% prior probability (8%). Among women with > or =10% prior probability, test result acceptors were most likely to be married (OR = 5.29, 95% CI = 1.82, 15.38, P = 0.002) and be less certain about their risk of developing cancer (OR = 3.18, 95% CI = 1.04, 9.80, P = 0.04). CONCLUSION: These results demonstrate that acceptance of BRCA1/2 test results may be limited among African American women. Being married and having less certainty about one's cancer risk may motivate acceptance of BRCA1/2 test results among African American women. It may be important to emphasize the possibility that BRCA1/2 test results may not clarify cancer risks during pre-test counseling with African American women to ensure informed decision-making about testing.
PURPOSE: This study evaluated rates of BRCA1 and BRCA2 (BRCA1/2) test result acceptance among African American women and identified determinants of test result acceptance. METHODS: Acceptance of BRCA1/2 test results was evaluated among 157 African American women at high and moderate risk for having a BRCA1/2 mutation who were offered genetic testing as part of a clinical genetic counseling research program. RESULTS: Twenty-two percent of women received BRCA1/2 test results. Test result acceptance differed between women with > or =10% prior probability of having a BRCA1/2 mutation (34%) and those who had a 5% prior probability (8%). Among women with > or =10% prior probability, test result acceptors were most likely to be married (OR = 5.29, 95% CI = 1.82, 15.38, P = 0.002) and be less certain about their risk of developing cancer (OR = 3.18, 95% CI = 1.04, 9.80, P = 0.04). CONCLUSION: These results demonstrate that acceptance of BRCA1/2 test results may be limited among African American women. Being married and having less certainty about one's cancer risk may motivate acceptance of BRCA1/2 test results among African American women. It may be important to emphasize the possibility that BRCA1/2 test results may not clarify cancer risks during pre-test counseling with African American women to ensure informed decision-making about testing.
Authors: Chanita Hughes Halbert; Vanessa Briggs; Marjorie Bowman; Brenda Bryant; Debbie Chatman Bryant; Ernestine Delmoor; Monica Ferguson; Marvella E Ford; Jerry C Johnson; Joseph Purnell; Rodney Rogers; Benita Weathers Journal: Health Educ Res Date: 2013-10-29
Authors: Altovise T Ewing; Nnenna Kalu; Gloria Cain; Lori H Erby; Luisel J Ricks-Santi; Eva Tetteyfio-Kidd Telemaque; Denise M Scott Journal: J Community Genet Date: 2019-03-14
Authors: Anita Y Kinney; Laurie E Steffen; Barbara H Brumbach; Wendy Kohlmann; Ruofei Du; Ji-Hyun Lee; Amanda Gammon; Karin Butler; Saundra S Buys; Antoinette M Stroup; Rebecca A Campo; Kristina G Flores; Jeanne S Mandelblatt; Marc D Schwartz Journal: J Clin Oncol Date: 2016-06-20 Impact factor: 44.544
Authors: Jonathan L Hills-Dunlap; Patrice Melvin; Dionne A Graham; Mark A Kashtan; Seema P Anandalwar; Shawn J Rangel Journal: JAMA Pediatr Date: 2019-07-01 Impact factor: 16.193
Authors: Charles R Jonassaint; Eunice R Santos; Crystal M Glover; Perry W Payne; Grace-Ann Fasaye; Nefertiti Oji-Njideka; Stanley Hooker; Wenndy Hernandez; Morris W Foster; Rick A Kittles; Charmaine D Royal Journal: Hum Genet Date: 2010-06-13 Impact factor: 4.132
Authors: Katarina M Sussner; Hayley S Thompson; Lina Jandorf; Tiffany A Edwards; Andrea Forman; Karen Brown; Nidhi Kapil-Pair; Dana H Bovbjerg; Marc D Schwartz; Heiddis B Valdimarsdottir Journal: Psychooncology Date: 2009-09 Impact factor: 3.894